1261622-39-2 Usage
General Description
5-Iodo-2-(trifluoromethyl)benzonitrile is a chemical compound with the molecular formula C8H3F3IN. It is a white to light yellow solid that is used as a building block in the synthesis of pharmaceuticals and agrochemicals. 5-iodo-2-(trifluoromethyl)benzonitrile is known to be a versatile reagent in organic synthesis, and its trifluoromethyl group makes it a useful precursor in the preparation of various fluorine-containing compounds. Additionally, the presence of the iodo and benzonitrile groups in the molecule gives it diverse reactivity and potential applications in medicinal chemistry and material science. Overall, 5-Iodo-2-(trifluoromethyl)benzonitrile is a valuable compound with wide-ranging synthetic utility and potential for producing biologically active molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1261622-39-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,6,2 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1261622-39:
(9*1)+(8*2)+(7*6)+(6*1)+(5*6)+(4*2)+(3*2)+(2*3)+(1*9)=132
132 % 10 = 2
So 1261622-39-2 is a valid CAS Registry Number.
1261622-39-2Relevant articles and documents
FURO[3,4-C]QUINOLINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION
-
Page/Page column 49; 50, (2013/03/26)
The present invention relates to compounds defined by formula (I), wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol
TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION
-
Page/Page column 177, (2012/03/10)
The present invention relates to compounds defined by formula I wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol ester transfer protein (CETP) and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme.
